CZA | IJH | CZA / IJH | |
Gain YTD | 5.399 | 6.629 | 81% |
Net Assets | 183M | 101B | 0% |
Total Expense Ratio | 0.69 | 0.05 | 1,380% |
Turnover | 112.00 | 18.00 | 622% |
Yield | 1.21 | 1.32 | 92% |
Fund Existence | 18 years | 25 years | - |
CZA | IJH | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago82% | 4 days ago87% |
Momentum ODDS (%) | 4 days ago80% | 4 days ago85% |
MACD ODDS (%) | 4 days ago87% | 4 days ago84% |
TrendWeek ODDS (%) | 4 days ago75% | 4 days ago84% |
TrendMonth ODDS (%) | 4 days ago81% | 4 days ago81% |
Advances ODDS (%) | 4 days ago81% | 4 days ago84% |
Declines ODDS (%) | 6 days ago74% | 6 days ago84% |
BollingerBands ODDS (%) | 4 days ago66% | 4 days ago80% |
Aroon ODDS (%) | 4 days ago79% | 4 days ago80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WGUSX | 15.25 | 0.21 | +1.40% |
Wasatch US Select Inst | |||
MAPPX | 27.49 | 0.26 | +0.95% |
Morgan Stanley Inst Advantage A | |||
LGOTX | 36.62 | 0.10 | +0.27% |
Lord Abbett Growth Opportunities R5 | |||
BMRRX | 34.71 | 0.09 | +0.26% |
BlackRock Mid-Cap Growth Equity R | |||
NRARX | 52.59 | -0.34 | -0.64% |
Neuberger Berman Quality Equity R3 |
A.I.dvisor tells us that CZA and IVZ have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZA and IVZ's prices will move in lockstep.
A.I.dvisor indicates that over the last year, IJH has been closely correlated with EVR. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if IJH jumps, then EVR could also see price increases.